{"id":751838,"date":"2023-04-27T01:04:48","date_gmt":"2023-04-27T05:04:48","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-report-first-quarter-2023-financial-results-and-business-update-on-may-4-2023\/"},"modified":"2023-04-27T01:04:48","modified_gmt":"2023-04-27T05:04:48","slug":"argenx-to-report-first-quarter-2023-financial-results-and-business-update-on-may-4-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-report-first-quarter-2023-financial-results-and-business-update-on-may-4-2023\/","title":{"rendered":"argenx to Report First Quarter 2023 Financial Results and Business Update on May 4, 2023"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"center\">\n        \n      <\/p>\n<p align=\"justify\">\n        <strong>April 27<\/strong><br \/>\n        <strong>, 202<\/strong><br \/>\n        <strong>3<\/strong><\/p>\n<p>        <strong>Amsterdam<\/strong><br \/>\n        <strong>, the Netherlands<\/strong> \u2013 argenx (Euronext &amp; Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that it will host a conference call and audio webcast on Thursday, May 4, 2023 at 2:30 pm CET (8:30 am ET) to discuss its first quarter 2023 financial results and provide a business update.<\/p>\n<p>A webcast of the live call may be accessed on the Investors section of the argenx website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=msp9RdH6k0v3tXSGHGfQblLZ9tvicDRC1mGkIwe6jez6HzdY3grBkc1fLQUs6TbGcP2Y9rnHeeGyDF1YTtBbGNkfaX1CbWUbU498Sb0hxIU=\" rel=\"nofollow noopener\" target=\"_blank\">argenx.com\/investors<\/a>. A replay of the webcast will be available on the argenx website for approximately one year following the presentation.<\/p>\n<p align=\"justify\">\n        <strong>Dial-in numbers:<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <em>Use the access <\/em><br \/>\n        <em>code 3810049 to join the call. Please dial in 15 minutes prior to the live call. <\/em>\n      <\/p>\n<p align=\"justify\">Belgium\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a032 800 50 201<br \/>France\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a033 800 943355<br \/>Netherlands\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a031 20 795 1090<br \/>United Kingdom\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a044 800 358 0970<br \/>United States \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a01 888 415 4250<br \/>Japan\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a081 3 4578 9752<br \/>Switzerland\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a041 43 210 11 32<\/p>\n<p align=\"justify\">\n        <strong>About argenx<\/strong>\n      <\/p>\n<p>argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx developed and is commercializing the first-and- only approved neonatal Fc receptor (FcRn) blocker in the U.S., Japan, the EU and the UK. The Company is evaluating efgartigimod in multiple serious autoimmune diseases and advancing several earlier stage experimental medicines within its therapeutic franchises. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=N6KrZXULifDJKa4sPlvjZ4C7hINmvw4jl5AsaSExpTjwNYjXPYa-BLgiX9_Z_ESeuSUPVKz3P34m_qjMB6uHo20roeVn02jImwx8cd0LGwI=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.argenx.com<\/a> and follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=H-JOcPHoyVgNHcxuYywYTR1C4P2MzFwJW4GlUzldCLlcQ9SBMrCVAMwv-lhYSmFT5bshF3y66HCA7aO8dLpjLXSfRierZmlIARxEpthNd5s=\" rel=\"nofollow noopener\" target=\"_blank\">LinkedIn<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qKkg50WIx7-AwhWYDQMTEb74tQupG-f_eWm0caQULsP7QNOl3loCFT_YzEv-rozZI6h4ANgWHVC5-xXpQWkkBA==\" rel=\"nofollow noopener\" target=\"_blank\">Twitter<\/a>, and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=sIy0INE4sbRJzO0Bjo817OqX2gV9tGbMr83BAs3c4zIt6H2eaZVc1DVPHNRZdKi7EM0ud9NBFhUFOnum_lfQw0LJVZ0B5FeQ1i0qWt64MWk=\" rel=\"nofollow noopener\" target=\"_blank\">Instagram<\/a>.<\/p>\n<p>For further information, please contact:<\/p>\n<p>\n        <strong>Media:<\/strong>\n      <\/p>\n<p>Erin Murphy<br \/>emurphy@argenx.com<\/p>\n<p>\n        <strong>Investors:<\/strong>\n      <\/p>\n<p>Beth DelGiacco<br \/>bdelgiacco@argenx.com<\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDgwNjI3NCM0MDE1MzI1MTMjMjAwMzc3Mg==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/MTVkZGNlZjEtZDM5ZC00NjIxLTg3NDQtNTdmZDZhNjkxODY3LTEwMTUzNDU=\/tiny\/argenx-SE.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>April 27 , 202 3 Amsterdam , the Netherlands \u2013 argenx (Euronext &amp; Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that it will host a conference call and audio webcast on Thursday, May 4, 2023 at 2:30 pm CET (8:30 am ET) to discuss its first quarter 2023 financial results and provide a business update. A webcast of the live call may be accessed on the Investors section of the argenx website at argenx.com\/investors. A replay of the webcast will be available on the argenx website for approximately one year following the presentation. Dial-in numbers: Use the access code 3810049 to join the call. Please dial in &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-report-first-quarter-2023-financial-results-and-business-update-on-may-4-2023\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;argenx to Report First Quarter 2023 Financial Results and Business Update on May 4, 2023&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-751838","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>argenx to Report First Quarter 2023 Financial Results and Business Update on May 4, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-report-first-quarter-2023-financial-results-and-business-update-on-may-4-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"argenx to Report First Quarter 2023 Financial Results and Business Update on May 4, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"April 27 , 202 3 Amsterdam , the Netherlands \u2013 argenx (Euronext &amp; Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that it will host a conference call and audio webcast on Thursday, May 4, 2023 at 2:30 pm CET (8:30 am ET) to discuss its first quarter 2023 financial results and provide a business update. A webcast of the live call may be accessed on the Investors section of the argenx website at argenx.com\/investors. A replay of the webcast will be available on the argenx website for approximately one year following the presentation. Dial-in numbers: Use the access code 3810049 to join the call. Please dial in &hellip; Continue reading &quot;argenx to Report First Quarter 2023 Financial Results and Business Update on May 4, 2023&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-report-first-quarter-2023-financial-results-and-business-update-on-may-4-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-27T05:04:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDgwNjI3NCM0MDE1MzI1MTMjMjAwMzc3Mg==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-report-first-quarter-2023-financial-results-and-business-update-on-may-4-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-report-first-quarter-2023-financial-results-and-business-update-on-may-4-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"argenx to Report First Quarter 2023 Financial Results and Business Update on May 4, 2023\",\"datePublished\":\"2023-04-27T05:04:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-report-first-quarter-2023-financial-results-and-business-update-on-may-4-2023\\\/\"},\"wordCount\":258,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-report-first-quarter-2023-financial-results-and-business-update-on-may-4-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDgwNjI3NCM0MDE1MzI1MTMjMjAwMzc3Mg==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-report-first-quarter-2023-financial-results-and-business-update-on-may-4-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-report-first-quarter-2023-financial-results-and-business-update-on-may-4-2023\\\/\",\"name\":\"argenx to Report First Quarter 2023 Financial Results and Business Update on May 4, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-report-first-quarter-2023-financial-results-and-business-update-on-may-4-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-report-first-quarter-2023-financial-results-and-business-update-on-may-4-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDgwNjI3NCM0MDE1MzI1MTMjMjAwMzc3Mg==\",\"datePublished\":\"2023-04-27T05:04:48+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-report-first-quarter-2023-financial-results-and-business-update-on-may-4-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-report-first-quarter-2023-financial-results-and-business-update-on-may-4-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-report-first-quarter-2023-financial-results-and-business-update-on-may-4-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDgwNjI3NCM0MDE1MzI1MTMjMjAwMzc3Mg==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDgwNjI3NCM0MDE1MzI1MTMjMjAwMzc3Mg==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-report-first-quarter-2023-financial-results-and-business-update-on-may-4-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"argenx to Report First Quarter 2023 Financial Results and Business Update on May 4, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"argenx to Report First Quarter 2023 Financial Results and Business Update on May 4, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-report-first-quarter-2023-financial-results-and-business-update-on-may-4-2023\/","og_locale":"en_US","og_type":"article","og_title":"argenx to Report First Quarter 2023 Financial Results and Business Update on May 4, 2023 - Market Newsdesk","og_description":"April 27 , 202 3 Amsterdam , the Netherlands \u2013 argenx (Euronext &amp; Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that it will host a conference call and audio webcast on Thursday, May 4, 2023 at 2:30 pm CET (8:30 am ET) to discuss its first quarter 2023 financial results and provide a business update. A webcast of the live call may be accessed on the Investors section of the argenx website at argenx.com\/investors. A replay of the webcast will be available on the argenx website for approximately one year following the presentation. Dial-in numbers: Use the access code 3810049 to join the call. Please dial in &hellip; Continue reading \"argenx to Report First Quarter 2023 Financial Results and Business Update on May 4, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-report-first-quarter-2023-financial-results-and-business-update-on-may-4-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-04-27T05:04:48+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDgwNjI3NCM0MDE1MzI1MTMjMjAwMzc3Mg==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-report-first-quarter-2023-financial-results-and-business-update-on-may-4-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-report-first-quarter-2023-financial-results-and-business-update-on-may-4-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"argenx to Report First Quarter 2023 Financial Results and Business Update on May 4, 2023","datePublished":"2023-04-27T05:04:48+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-report-first-quarter-2023-financial-results-and-business-update-on-may-4-2023\/"},"wordCount":258,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-report-first-quarter-2023-financial-results-and-business-update-on-may-4-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDgwNjI3NCM0MDE1MzI1MTMjMjAwMzc3Mg==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-report-first-quarter-2023-financial-results-and-business-update-on-may-4-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-report-first-quarter-2023-financial-results-and-business-update-on-may-4-2023\/","name":"argenx to Report First Quarter 2023 Financial Results and Business Update on May 4, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-report-first-quarter-2023-financial-results-and-business-update-on-may-4-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-report-first-quarter-2023-financial-results-and-business-update-on-may-4-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDgwNjI3NCM0MDE1MzI1MTMjMjAwMzc3Mg==","datePublished":"2023-04-27T05:04:48+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-report-first-quarter-2023-financial-results-and-business-update-on-may-4-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-report-first-quarter-2023-financial-results-and-business-update-on-may-4-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-report-first-quarter-2023-financial-results-and-business-update-on-may-4-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDgwNjI3NCM0MDE1MzI1MTMjMjAwMzc3Mg==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDgwNjI3NCM0MDE1MzI1MTMjMjAwMzc3Mg=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-report-first-quarter-2023-financial-results-and-business-update-on-may-4-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"argenx to Report First Quarter 2023 Financial Results and Business Update on May 4, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/751838","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=751838"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/751838\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=751838"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=751838"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=751838"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}